Literature DB >> 7012935

PGH2, TxA2 and PGI2 have potent and differentiated actions on human uterine contractility.

L Wilhelmsson, M Wikland, N Wiqvist.   

Abstract

The contractile response to three different prostanoids of the isolated human myometrium and the different layers of the uterotubal junction (UTJ) was studied in vitro. The prostaglandin endoperoxide, PGH2, stimulated contractility of both the myometrium and the outer and inner muscle layers of the UTJ, whereas the intermediate layer of the UTJ was inhibited. Thromboxane A2 generated from PGH2 and a thromboxane synthase preparation caused a stimulation of both the myometrium and all three layers of the UTJ. The stimulatory response to TxA2 occurred at concentrations as low as 50-70 pg/ml. The sodium salt of PGi2 was found to relax both the myometrium and all the layers of the UTJ. Intravenous administration of PGI2 in repeated doses between 2-8 microgram induced facial flushing and headache but had little if any effect on in vivo uterine contractility. At least under in vitro conditions, these short-lived prostanoids and/or their metabolites apparently have a specific action on uterine contractility, an action which is manifested at comparatively low concentrations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012935     DOI: 10.1016/0090-6980(81)90145-3

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  7 in total

1.  Not a mouse stirring: deletion of the EP2 and love's labor's lost.

Authors:  S Austin; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

3.  Contribution to the pathogenesis of dysmenorrhea.

Authors:  H P Zahradnik; M Breckwoldt
Journal:  Arch Gynecol       Date:  1984

4.  Blood pressure dynamics during pregnancy and spontaneous preterm birth.

Authors:  Jun Zhang; Jose Villar; Wenyu Sun; Mario Merialdi; Hany Abdel-Aleem; Matthews Mathai; Mohamed Ali; Kai F Yu; Nelly Zavaleta; Manorama Purwar; Thi Nhu Ngoc Nguyen; Liana Campodonico; Sihem Landoulsi; Marshall Lindheimer; Guillermo Carroli
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

5.  Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.

Authors:  Bo Zhu; Yumei Chen; Xiaolu Shen; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-10-10       Impact factor: 5.211

Review 6.  The Pathogenesis of Adenomyosis vis-à-vis Endometriosis.

Authors:  Sun-Wei Guo
Journal:  J Clin Med       Date:  2020-02-10       Impact factor: 4.241

7.  Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.

Authors:  S Battersby; H O D Critchley; A J de Brum-Fernandes; H N Jabbour
Journal:  Reproduction       Date:  2004-01       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.